Market Overview:
The global new-born screening market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of birth defects and genetic disorders, rising awareness about newborn screening, and technological advancements in newborn screening tests. The global new-born screening market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into tandem mass spectrometry (TMS), pulse oximetry screening technology (POS), DNA-based assays (DBS), hearing screen technology (HST), and others. Tandem mass spectrometry accounted for the largest share of the global new-born screening market in 2017 owing to its high accuracy and sensitivity. On the basis of application, hospitals accounted for the largest share of the global new-born screening market in 2017 owing to increased demand for early diagnosis and treatment options for newborns with genetic disorders or birth defects.
Product Definition:
The definition of New-Born Screening is a process that tests newborns for certain medical conditions that may not be apparent at birth. The importance of New-Born Screening is that it can detect health problems in babies early on, which can allow for treatment to begin sooner.
Tandem Mass Spectrometry:
Tandem mass spectrometry (MS/MS) is an analytical technology that allows the separation and identification of biomolecules, ions, and peptides in a single instrument. MS/MS technique provides higher speed with respect to conventional techniques such as LC-ESI-TOF or LC-MS; it also has the advantage of being able to analyze larger samples in less time.
Pulse Oximetry Screening Technology:
Pulse oximetry screening technology is used for newborn screening (NBS) to detect congenital heart defects (CHD) in the fetus. The technology involves testing of oxygen saturation level in the blood of a fetus during pregnancy.
The test works on the principle that low oxygen levels indicate a problem with blood flow.
Application Insights:
The others segment dominated the global market in 2017 and is expected to grow at a CAGR of XX% over the forecast period owing to its low adoption rate among other applications such as home healthcare. New-born screening by means of pulse oximetry screening technology is widely adopted among clinics, while DNA-based assays are majorly used in hospitals for newborn screening globally.
Hearing screen technology is anticipated to witness lucrative growth during the forecast period owing to its increasing adoption rate across various regions including North America and Europe due to rising awareness about hearing loss amongst parents, which eventually leads towards early detection of hearing impairment in babies. Furthermore, tandem mass spectrometry based testing has also emerged as a potential alternative for widespread use with several advantages such as ease of operation and better accuracy compared with other conventional methods such as optical imaging or acoustics imaging that are commonly used for initial assessment before referring infants out for further evaluation by an audiologist or speech therapist.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of technologically advanced newborn screening tools and a large number of companies marketing these products in this region. Moreover, government initiatives are also being undertaken to increase awareness regarding neonatal screening programs in North America countries. For instance, according to statistics published by CDC’s National Center for Health Statistics (NCHS), from 2011 through 2014, about 95% of all U.S.-born infants were screened with at least one method by their second birthday; whereas only 3% were not screened at all or not screene d using currently available technology (measured blood pressure).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure especially in developing economies such as India and China.
Growth Factors:
- Increasing incidence of birth defects and genetic disorders: The global incidence of birth defects is estimated to be around 3-5% and the number of children born with genetic disorders is increasing every year. This is expected to drive the demand for New-Born Screening services in the coming years.
- Growing awareness about New-Born Screening: There has been a growing awareness among parents about the benefits of New-Born Screening tests in detecting various health problems in newborns. This is likely to boost demand for these services in the near future.
- Rising healthcare expenditure: Healthcare expenditure is on rise globally, owing to increasing prevalence of chronic diseases and technological advancements in healthcare sector. This is expected to create lucrative opportunities for growth of New-Born Screening market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
New-Born Screening Market Research Report
By Type
Tandem Mass Spectrometry, Pulse Oximetry Screening Technology, DNA-Based Assays, Hearing Screen Technology, Others
By Application
Hospitals, Clinics, Nursing Homes, Others
By Companies
GE Healthcare, Trivitron Healthcare, AB Sciex, Perkinelmer, Bio-Rad Laboratories, Agilent Technologies, Medtronic, Masimo, Waters, Natus Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global New-Born Screening Market Report Segments:
The global New-Born Screening market is segmented on the basis of:
Types
Tandem Mass Spectrometry, Pulse Oximetry Screening Technology, DNA-Based Assays, Hearing Screen Technology, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Nursing Homes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Trivitron Healthcare
- AB Sciex
- Perkinelmer
- Bio-Rad Laboratories
- Agilent Technologies
- Medtronic
- Masimo
- Waters
- Natus Medical
Highlights of The New-Born Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tandem Mass Spectrometry
- Pulse Oximetry Screening Technology
- DNA-Based Assays
- Hearing Screen Technology
- Others
- By Application:
- Hospitals
- Clinics
- Nursing Homes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the New-Born Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
New-born screening is a process of identifying babies who may have health problems so that they can be monitored and treated early.
Some of the major companies in the new-born screening market are GE Healthcare, Trivitron Healthcare, AB Sciex, Perkinelmer, Bio-Rad Laboratories, Agilent Technologies, Medtronic, Masimo, Waters, Natus Medical.
The new-born screening market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 New-Born Screening Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 New-Born Screening Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 New-Born Screening Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the New-Born Screening Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global New-Born Screening Market Size & Forecast, 2020-2028
4.5.1 New-Born Screening Market Size and Y-o-Y Growth
4.5.2 New-Born Screening Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tandem Mass Spectrometry
5.2.2 Pulse Oximetry Screening Technology
5.2.3 DNA-Based Assays
5.2.4 Hearing Screen Technology
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Nursing Homes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global New-Born Screening Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 New-Born Screening Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tandem Mass Spectrometry
9.6.2 Pulse Oximetry Screening Technology
9.6.3 DNA-Based Assays
9.6.4 Hearing Screen Technology
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Nursing Homes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tandem Mass Spectrometry
10.6.2 Pulse Oximetry Screening Technology
10.6.3 DNA-Based Assays
10.6.4 Hearing Screen Technology
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Nursing Homes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tandem Mass Spectrometry
11.6.2 Pulse Oximetry Screening Technology
11.6.3 DNA-Based Assays
11.6.4 Hearing Screen Technology
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Nursing Homes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tandem Mass Spectrometry
12.6.2 Pulse Oximetry Screening Technology
12.6.3 DNA-Based Assays
12.6.4 Hearing Screen Technology
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Nursing Homes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tandem Mass Spectrometry
13.6.2 Pulse Oximetry Screening Technology
13.6.3 DNA-Based Assays
13.6.4 Hearing Screen Technology
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Nursing Homes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 New-Born Screening Market: Competitive Dashboard
14.2 Global New-Born Screening Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Trivitron Healthcare
14.3.3 AB Sciex
14.3.4 Perkinelmer
14.3.5 Bio-Rad Laboratories
14.3.6 Agilent Technologies
14.3.7 Medtronic
14.3.8 Masimo
14.3.9 Waters
14.3.10 Natus Medical
